🌱 A small step in our journey to make precision health more accessible
We’re humbled to be featured in Nature, where our co-founders shared how we’re working to make genetic screening more accessible and impactful — starting with a nationwide rollout for leprosy patients in Indonesia, one of the countries most affected by the disease.
With support from local communities in remote Papua, we’ve helped reduce mortality from nearly 10% to almost zero by identifying patients at risk of severe reactions to standard treatment. This initiative is now expanding to Nepal and India, and we’re just getting started.
From personalized treatment for infectious diseases to advancing pharmacogenomics, cancer, cardiovascular, and diabetes screening, we remain committed to building solutions that are deeply rooted in Southeast Asia — for Southeast Asia.
We’re especially grateful for the support from partners in Singapore, where we spun out of A*STAR in 2016, and continue to grow within a vibrant and supportive innovation ecosystem.
🧬 The future of precision health is local, scalable, and inclusive. Read the full story below.
#NalaGenetics #PrecisionHealth #GeneticTesting #Pharmacogenomics #SoutheastAsia #Innovation #Healthcare #Biotech #ImpactDriven
Leave a Reply